VEGF modulates early heart valve formation

Anatomical Record - Part A Discoveries in Molecular, Cellular, and Evolutionary Biology

Volumn 271, Issue 1, 2003, Pages 202-208

  Dor, Yuval ^a   Klewer, Scott E ^b   McDonald, John A ^c   Keshet, Eli ^a   Camenisch, Todd D ^b,d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

Author keywords

Development; Endocardial cushions; Heart; Hypoxia; VEGF

Indexed keywords

COLLAGEN GEL; COLLAGEN TYPE 1; VASCULOTROPIN;

ANIMAL TISSUE; ARTICLE; CONGENITAL HEART MALFORMATION; ENDOCARDIUM; EXPLANT; FEMALE; HEART DEVELOPMENT; HEART VALVE; HYPOXIA; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TISSUE CULTURE;

EID: 0042576951     PISSN: 0003276X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ar.a.10026     Document Type: Article

References (35)

1. Baldwin HS. 1996. Early embryonic vascular development. Cardiovasc Res 31:E34-E45.
2. Boyer AS, Ayerinskas II, Vincent EB, McKinney LA, Weeks DL, Runyan RB. 1999. TGFbeta2 and TGFbeta3 have separate and sequential activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Biol 208:530-545.
3. Boyer AS, Runyan RB. 2001. TGFbeta type III and TGFbeta type II receptors have distinct activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Dyn 221:454-459.
4. Brown CB, Boyer AS, Runyan RB, Barnett JV. 1996. Antibodies to the Type II TGFbeta receptor block cell activation and migration during atrioventricular cushion transformation in the heart. Dev Biol 174:248-257.
5. Brown CB, Boyer AS, Runyan RB, Barnett JV. 1999. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 283:2080-2082.
6. Camenisch TD, Spicer AP, Brehm-Gibson T, Biesterfeldt J, Augustine ML, Calabro AJ, Kubalak S, Klewer SE, McDonald JA. 2000. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest 106:349-360.
7. Camenisch TD, Molin DGM, Person A, Runyan RB, Gittenberger-de Groot AC, McDonald JA, Klewer SE. 2002. Temporal and distinct TGFb ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev Biol 248:170-181.
8. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439.
9. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
10. Clemmer TP, Telford IR. 1966. Abnormal development of the rat heart during prenatal hypoxic stress. Proc Soc Exp Biol Med 121:800-803.
11. DeSesso JM. 1987. Maternal factors in developmental toxicity. Teratog Carcinog Mutagen 7:225-240.
12. Dor Y, Keshet E. 1997. Ischemia-driven angiogenesis. Trends Cardiol Med 7:289-294.
13. Dor Y, Camenisch TD, Itin A, Fishman GI, McDonald JA, Carmeliet P, Keshet E. 2001. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart disease. Development 128:1531-1538.
14. Eisenberg LM, Markwald RR. 1995. Molecular regulation of atrioven-tricular valvuloseptal morphogenesis. Circ Res 77:1-6.
15. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW. 1996. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442.
16. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5:623-628.
17. Ingalls TH, Curley FJ, Prindle RA. 1952. Experimental production of congenital anomolies: timing and degree of anoxia as factors causing fetal deaths and congenital anomalies in the mouse. N Engl J Med 247:758-768.
18. Isner JM. 2001. Still more debate over VEGF. Nat Med 7:639-641.
19. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149-162.
20. Jaffee OC. 1974. The effects of moderate hypoxia and moderate hypoxia plus hypercapnea on cardiac development in chick embryos. Teratology 10:275-281.
21. Lakkis MM, Epstein JA. 1998. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125:4359-4367.
22. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM. 2000. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 102:898-901.
23. Lee YM, Jeong CH, Koo SY, Son MJ, Song HS, Bae SK, Raleigh JA, Chung HY, Yoo MA, Kim KW. 2001. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Dev Dyn 220:175-186.
24. Lueder FL, Kim SB, Buroker CA, Bangalore SA, Ogata ES. 1995. Chronic maternal hypoxia retards fetal growth and increases glucose utilization of select fetal tissues in the rat. Metabolism 44:532-537.
25. Markwald RR, Fitzharris TP, Bolender DL, Bernanke DH. 1979. Structural analysis of cell: matrix association during the morphogenesis of atrioventricular cushion tissue. Dev Biol 69:634-654.
26. Markwald RR, Krook JM, Kitten GT, Runyan RB. 1981. Endocardial cushion tissue development: structural analyses on the attachment of extracellular matrix to migrating mesenchymal cell surfaces. Scan Electron Microsc Pt 2:261-274.
27. Miao CY, Zuberbuhler JS, Zuberbuhler JR. 1988. Prevalence of con genital cardiac anomalies at high altitude. J Am Coll Cardiol 12:224-228.
28. Miquerol L, Langille BL, Nagy A. 2000. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development 127:3941-3946.
29. Olson EN, Srivastava D. 1996. Molecular pathways controlling heart development. Science 272:671-676.
30. Ritz B, Yu F, Fruin S, Chapa G, Shaw GM, Harris JA. 2002. Ambient air pollution and risk of birth defects in Southern California. Am J Epidemiol 155:17-25.
31. Runyan RB, Markwald RR. 1983. Invasion of mesenchyme into three-dimensional collagen gels: a regional and temporal analysis of interaction in embryonic heart tissue. Dev Biol 95:108-114.
32. Ryan HE, Lo J, Johnson RS. 1998. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17:3005-3015.
33. Saadeh PB, Mehrara BJ, Steinbrech DS, Spector JA, Greenwald JA, Chin GS, Ueno H, Gittes GK, Longaker MT. 2000. Mechanisms of fibroblast growth factor-2 modulation of vascular endothelial growth factor expression by osteoblastic cells. Endocrinology 141:2075-2083.
34. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
35. Semenza GL, Agani F, Iyer N, Kotch L, Laughner E, Leung S, Yu A. 1999. Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann N Y Acad Sci 874:262-268.